What happened?
Shares of eyecare company Bausch + Lomb (NYSE: BLCO) jumped 8.7% in the afternoon session after the company reported third-quarter 2026 revenue of $1.375 billion and raised its full-year 2026 revenue guidance.
According to a company press release, Bausch + Lomb reported total revenue of $1.375 billion, up 7% compared to the prior-year period, with constant currency revenue rising 8% across its vision care, pharmaceutical, and surgical divisions.
Adjusted earnings per share was 34 cents, up from 18 cents in the same quarter last year and above analysts' consensus estimates of 22 cents. Adjusted EBITDA was $325 million, above analyst estimates of $270.9 million.
For the full year, the company lifted its revenue guidance to $5.5 billion at the midpoint from $5.49 billion. Full-year EBITDA guidance of $1.12 billion at the midpoint was also above analyst estimates of $1.05 billion.
Is now the time to buy Bausch + Lomb? Access our full analysis report here, it’s free.
What is the market telling us
Bausch + Lomb’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 11 months ago when the stock gained 4.6% on the news that comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally.
Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Bausch + Lomb is up 16.8% since the beginning of the year, and at $19.37 per share, it has set a new 52-week high. Investors who bought $1,000 worth of Bausch + Lomb’s shares at the IPO in May 2022 would now be looking at an investment worth $968.60.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
